Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
SAGE documentation
GRADE table
Clear all
Type of publications
SAGE documentation
(66)
Topics
GRADE table
(66)
Available to download in languages
English (EN)
(66)
Regions
Countries
Diseases
Cholera
(1)
COVID-19
(2)
Dengue
(6)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Hepatitis A
(6)
Human papillomavirus (HPV)
(9)
Influenza
(11)
Japanese encephalitis
(9)
Measles
(6)
Meningococcal disease
(4)
Pertussis
(2)
Rubella
(1)
Typhoid
(2)
Vaccine topics
Target population
Publication date
66 results found
2015
∙
SAGE
What is the effectiveness of inactivated Vero cell-derived JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
2015
∙
SAGE
What is the effectiveness of live attenuated JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
2015
∙
SAGE
What is the effectiveness of live recombinant JE vaccine in preventing JE disease in vaccinees living in JE-endemic areas?
2015
∙
SAGE
What is the risk of serious adverse events following vaccination with inactivated Vero cell-derived JE vaccine?
2014
∙
SAGE
HPV vaccination of males to reduce incidence of cervical cancer in females
2013
∙
SAGE
Hib vaccination schedules: three primary doses plus one booster dose versus two primary doses plus one booster dose
2013
∙
SAGE
Hib vaccination schedules: three primary doses plus one booster versus three primary doses only
2013
∙
SAGE
Hib vaccination schedules: three primary doses versus two primary doses plus one booster dose
2013
∙
SAGE
Level of clinical protection conferred by a complete primary series of Haemophilus influenzae type b (Hib) vaccination
2012
∙
SAGE
Hepatitis A vaccine and post-exposure prophylaxis
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register